spacer
home > ict > spring 2018 > the engagement equation
PUBLICATIONS
International Clinical Trials

The Engagement Equation

Patient engagement not only impacts study timelines and budgets, but it is a key driver for clinical trial success. As the marketplace has become more dynamic with the introduction of new tools and technologies, engagement pathways have expanded. As a result, a corresponding shift in mindset needs to occur. Engagement must be recognised as starting well before the patientís first visit, at the time of study awareness. Recruitment and retention must also be recognised as unified under the umbrella of engagement, rather than as separate concepts. Finally, a shift is needed from a patient-centric mindset to a study-centric mindset, where emphasis moves to the study community and the tools that can be utilised to maximise study efficiency.

Being Study-Centric


Identifying the problem, defining success, and building solutions are the cornerstones for study centricity. To be effective, one needs to identify potential roadblocks that may impact study efficiency. They may be protocolbased, such as the number or frequency of study visits, impacting patients and sites alike, or they may impact the entire study community, such as the overall length of the study. However, once identified, defining success with key performance indicators (KPIs) is important. In the event of a burdensome visit schedule, limiting the number of schedule changes could be considered. Once the KPI has been determined, one is then in a position to build the solution. In this case, perhaps it is a travel programme designed to remove burden, supporting patients getting to and from study appointments while also offering a reimbursement option.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Aaron Fleishman at BBK Worldwide oversees strategic consultation and product development and provides insights into patient recruitment technology development trends. He is responsible for building strategic partnerships, developing innovative products for patient-centric clinical trials, and consulting the pharma industry on implementing new innovative ideas.

Sarah Mandracchia at BBK Worldwide has more than a decade of experience translating complex market research and patient insights into effective media strategies for global patient recruitment campaigns. Sarah is responsible for upholding strategic direction and imperatives throughout the lifecycle of clinical trial programmes.

spacer
Aaron Fleishman
spacer
spacer
spacer
Sarah Mandracchia
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Destiny Pharma appoints MedPharm to develop new XF-platform drug formulations

Destiny Pharma, a clinical stage biotechnology company focused on the development of novel antimicrobial drugs, is pleased to announce that it has appointed MedPharm as its expert partner to develop new topical formulations of the Companyís novel XF-platform compounds. These new treatments for dermal and ocular infections are part of its second clinical programme to address the global problem of anti-microbial resistance (AMR). MedPharm is a world leading contract provider of topical and transdermal product design and formulation development services using sophisticated in vitro models to de-risk development programmes.
More info >>

White Papers

Detecting Integrity Breaches in a range of Pharmaceutical Blister Package Types using Sepha VisionScan

Sepha Limited

Demonstrating the integrity of pharmaceutical blister packs is critically important, as any defects can affect the shelf life and efficacy of the contents. Compared to bulk packaging, blister packs offer improved product integrity, tamper evidence and reduce the likelihood of misuse. Packs can be composed of either a thermoformed polymer or cold formed aluminium tray, with a number of individual pockets to hold the product. After the tablets or capsules are placed in the pockets, the packs are heat sealed with a paper or foil laminate sheet. These various stages can be completed separately or integrated into a single form, fill and seal process. There is a risk of microbial containment or degradation of the contents if any defects are present in the packaging. Such defects can take the form of rips or pinholes in the tray, or lid materials, faulty seals and channel leaks between pockets.
More info >>

 
Industry Events

Nordic Life Science Days 10/12 September 2019

10-12 September 2019, Malmo Sweden

Nordic Life Science Days is the largest Nordic partnering conference for the global Life Science industry. Bringing together the best talents in Life Science, offering amazing networking and partnering opportunities, providing inputs and content on the most recent trends. Nordic Life Science Days attracts leading decision makers from the Life Science sector, not only from biotech, pharma and medtech but also from finances, research, policy and regulatory authorities.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement